Michael Prados

Michael Prados

UNVERIFIED PROFILE

Are you Michael Prados?   Register this Author

Register author
Michael Prados

Michael Prados

Publications by authors named "Michael Prados"

Are you Michael Prados?   Register this Author

100Publications

3816Reads

43Profile Views

Attitudes toward fertility and fertility preservation in women with glioma.

Neurooncol Pract 2019 May 26;6(3):218-225. Epub 2018 Sep 26.

Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npy036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656302PMC
May 2019

Using genomics to guide treatment for glioblastoma.

Pharmacogenomics 2018 10 11;19(15):1217-1229. Epub 2018 Sep 11.

Department of Neurological Surgery, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2018-0078DOI Listing
October 2018

Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy.

Neuro Oncol 2018 01;20(2):249-258

Center for Neuro-Oncology, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts (P.Y.W, J.D.); The University of Texas MD Anderson Cancer Center, Houston, Texas (J.dG.); University of California, San Francisco, Helen Diller Cancer Center Building, San Francisco, California (M.D.P.); Duke University, Durham, North Carolina (D.A.R., A.D.); Neuro-Oncology Center, University of Virginia Health System, Charlottesville, Virginia (D.S.); University of Washington, Department of Neurology, Fred Hutchinson Cancer Research Center, Seattle, Washington (M.C.); Henry Ford Health System, Detroit, Michigan (T.M.); Exelixis, South San Francisco, California (J.H., J.P., R.W.); The Ronald Reagan UCLA Medical Center, Los Angeles, California (T.F.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777496PMC
January 2018

Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy.

Neuro Oncol 2018 01;20(2):259-267

The Ronald Reagan UCLA Medical Center, Los Angeles, California (T.F.C.); Center for Neuro-Oncology, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts (P.Y.W., J.D.); The University of Texas MD Anderson Cancer Center, Houston, Texas (J.dG.); University of California San Francisco, San Francisco, California (M.D.P.); Duke University, Durham, North Carolina (D.A.R., A.D.); Neuro-Oncology Center, University of Virginia Health System, Charlottesville, Virginia (D.S.); University of Washington, Department of Neurology, Fred Hutchinson Cancer Research Center, Seattle, Washington (M.C.); Henry Ford Health System, Detroit, Michigan (T.M.); Exelixis, South San Francisco, California (J.P., J.H., R.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777491PMC
January 2018

Clinical trial endpoints for patients with gliomas.

Neurooncol Pract 2017 Dec 14;4(4):201-208. Epub 2017 Feb 14.

Department of Neurological Surgery, University of California San Francisco, San Francisco, California (J.W.T., A.M.M., N.B., M.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npw034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655446PMC
December 2017

A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.

Neuro Oncol 2017 Aug;19(8):1135-1144

University of California San Francisco, San Francisco, California; Boston Children's Hospital, Boston, Massachusetts; Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; St Jude Children's Research Hospital, Memphis, Tennessee; Lurie Children's Hospital, Chicago, Illinois; Children's National Medical Center, Washington, DC; Duke University Medical Center, Durham, North Carolina; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now282DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570236PMC
August 2017

Precision knockdown of EGFR gene expression using radio frequency electromagnetic energy.

J Neurooncol 2017 Jun 22;133(2):257-264. Epub 2017 Apr 22.

Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, 550 17th Avenue, Seattle, WA, 98122, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-017-2440-xDOI Listing
June 2017

A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma.

Cancer Chemother Pharmacol 2017 03 23;79(3):603-610. Epub 2017 Feb 23.

Division of Neuro-oncology, Department of Neurological Surgery, University of California, San Francisco (UCSF), 505 Parnassus Avenue M779, San Francisco, CA, 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-017-3247-3DOI Listing
March 2017

Combined BRAF and MEK blockade for BRAF-mutant gliomas.

J Neurooncol 2017 02 15;131(3):495-505. Epub 2016 Nov 15.

Department of Pediatrics, University of California San Francisco, 1450 3rd Street, San Francisco, CA, 94158, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-016-2333-4
Publisher Site
http://dx.doi.org/10.1007/s11060-016-2333-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560871PMC
February 2017

Acquired resistance to BRAF inhibition in BRAFV600E mutant gliomas.

Oncotarget 2017 Jan;8(1):583-595

Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.11882DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352180PMC
January 2017

Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth.

Neuro Oncol 2016 11 1;18(11):1519-1528. Epub 2016 Jul 1.

Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (R.H., A.Z., C.D.J., A.M.S., C.H.); Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (R.H., C.D.J.); Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (A.H.S., S.-Y.C.), Northwestern Brain Tumor Institute, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (R.H., R.R.L., S.G., A.M.S., A.P.M., A.H.S., S.-Y.C., C.H., C.D.J.); Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (R.H., R.R.L., S.G., A.P.M., A.H.S., S.-Y.C., C.H., C.D.J.); Chemistry of Life Processes Institute, Northwestern University, Evanston, Illinois (A.P.M., C.D.J.); Department of Pediatrics, Division of Hematology/Oncology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois (R.R.L., S.G.); Department of Neurological Surgery, University of California San Francisco, San Francisco, California (S.M., M.D.P.); Department of Pediatrics, University of California San Francisco, San Francisco, California (S.M.); Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts (D.A.H.-K.); Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota (J.N.S.); Lombardi Cancer Center, Georgetown University, Washington, DC (T.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063519PMC
November 2016

Biopsy for diffuse intrinsic pontine glioma: a reappraisal.

J Neurosurg Pediatr 2016 Sep 6;18(3):390-1. Epub 2016 May 6.

University of California, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2015.6.PEDS15374DOI Listing
September 2016

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.

Authors:
Vijay Ramaswamy Thomas Hielscher Stephen C Mack Alvaro Lassaletta Tong Lin Kristian W Pajtler David T W Jones Betty Luu Florence M G Cavalli Kenneth Aldape Marc Remke Martin Mynarek Stefan Rutkowski Sridharan Gururangan Roger E McLendon Eric S Lipp Christopher Dunham Juliette Hukin David D Eisenstat Dorcas Fulton Frank K H van Landeghem Mariarita Santi Marie-Lise C van Veelen Erwin G Van Meir Satoru Osuka Xing Fan Karin M Muraszko Daniela P C Tirapelli Sueli M Oba-Shinjo Suely K N Marie Carlos G Carlotti Ji Yeoun Lee Amulya A Nageswara Rao Caterina Giannini Claudia C Faria Sofia Nunes Jaume Mora Ronald L Hamilton Peter Hauser Nada Jabado Kevin Petrecca Shin Jung Luca Massimi Massimo Zollo Giuseppe Cinalli László Bognár Almos Klekner Tibor Hortobágyi Sarah Leary Ralph P Ermoian James M Olson Jeffrey R Leonard Corrine Gardner Wieslawa A Grajkowska Lola B Chambless Jason Cain Charles G Eberhart Sama Ahsan Maura Massimino Felice Giangaspero Francesca R Buttarelli Roger J Packer Lyndsey Emery William H Yong Horacio Soto Linda M Liau Richard Everson Andrew Grossbach Tarek Shalaby Michael Grotzer Matthias A Karajannis David Zagzag Helen Wheeler Katja von Hoff Marta M Alonso Teresa Tuñon Ulrich Schüller Karel Zitterbart Jaroslav Sterba Jennifer A Chan Miguel Guzman Samer K Elbabaa Howard Colman Girish Dhall Paul G Fisher Maryam Fouladi Amar Gajjar Stewart Goldman Eugene Hwang Marcel Kool Harshad Ladha Elizabeth Vera-Bolanos Khalida Wani Frank Lieberman Tom Mikkelsen Antonio M Omuro Ian F Pollack Michael Prados H Ian Robins Riccardo Soffietti Jing Wu Phillipe Metellus Uri Tabori Ute Bartels Eric Bouffet Cynthia E Hawkins James T Rutka Peter Dirks Stefan M Pfister Thomas E Merchant Mark R Gilbert Terri S Armstrong Andrey Korshunov David W Ellison Michael D Taylor

J Clin Oncol 2016 07 6;34(21):2468-77. Epub 2016 Jun 6.

Vijay Ramaswamy, Stephen C. Mack, Alvaro Lassaletta, Betty Luu, Florence M.G. Cavalli, Uri Tabori, Ute Bartels, Eric Bouffet, Cynthia E. Hawkins, James T. Rutka, Peter Dirks, and Michael D. Taylor, The Hospital for Sick Children; Vijay Ramaswamy, Kenneth Aldape, James T. Rutka, and Michael D. Taylor, University of Toronto; Kenneth Aldape, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario; Christopher Dunham and Juliette Hukin, British Columbia Children's Hospital; Juliette Hukin, University of British Columbia, Vancouver, British Columbia; David D. Eisenstat, Dorcas Fulton, and Frank K.H. van Landeghem, University of Alberta, Edmonton; Jennifer A. Chan, University of Calgary, Calgary, Alberta; Nada Jabado and Kevin Petrecca, McGill University, Montreal, Quebec, Canada; Thomas Hielscher, Kristian W. Pajtler, David T.W. Jones, Marcel Kool, Stefan M. Pfister, and Andrey Korshunov, German Cancer Research Center; Stefan M. Pfister, University Hospital Heidelberg, Heidelberg; Marc Remke, University Hospital Düsseldorf, Düsseldorf; Martin Mynarek, Stefan Rutkowski, and Katja von Hoff, University Medical Center Hamburg-Eppendorf, Hamburg; Ulrich Schüller, Ludwig-Maximilians-Universität, Munich, Germany; Stephen C. Mack, Cleveland Clinic Foundation, Cleveland; Maryam Fouladi, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Tong Lin, Amar Gajjar, Thomas E. Merchant, and David W. Ellison, St Jude Children's Research Hospital, Memphis; Lola B. Chambless, Vanderbilt Medical Center, Nashville, TN; Sridharan Gururangan, Roger E. McLendon, and Eric S. Lipp, Duke University, Durham; Jing Wu, University of North Carolina at Chapel Hill, Chapel Hill, NC; Mariarita Santi, Children's Hospital of Philadelphia; Lyndsey Emery, Hospital of the University of Pennsylvania, Philadelphia; Ronald L. Hamilton and Ian F. Pollack, University of Pittsburgh School of Medicine; Frank Lieberman, University of Pittsburgh Medical Cen

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.7825DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962737PMC
July 2016

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study.

Neuro Oncol 2016 Apr 8;18(4):557-64. Epub 2015 Oct 8.

University of California at San Francisco, San Francisco, California (N.B., A.P., J.P., A.M.M, M.P.); Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (H.C.); The University of Texas MD Anderson Cancer Center, Houston, Texas (J.F.D.G.); Department of Neurology, Memorial Sloan Kettering Cancer Hospital, New York, New York (A.M.O.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (L.N., P.Y.W., S.H., K.L.L.); UCLA Medical Center, Los Angeles, California (T.F.C.); Plexxikon Inc., Berkeley, California (A.M., B.L.W., K.B.N., H.H.H.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (K.L.L.); Department of Pathology, Memorial Sloan Kettering Cancer Hospital, New York, New York (J.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov245DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799682PMC
April 2016

Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience.

J Neurooncol 2016 Jan;126(1):193-200

Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston Children's Hospital, Harvard Medical School, 450 Brookline Ave, D1622, Boston, MA, 02215-5418, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-015-1959-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826306PMC
January 2016

Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials.

Transl Oncol 2015 Dec;8(6):446-55

Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA United States; UCSF/UCB Joint Graduate Group in Bioengineering, University of California, San Francisco, San Francisco, CA United States; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2015.10.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700297PMC
December 2015

Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS Tumors.

J Clin Oncol 2015 Oct 17;33(28):3186-92. Epub 2015 Aug 17.

Mrinal M. Gounder, Armando J. Sanchez, and Lisa M. DeAngelis, Memorial Sloan-Kettering Cancer Center and Weil Cornell Medical School, New York, NY; Lakshmi Nayak and Patrick Y. Wen, Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School; Alona Muzikansky, Massachusetts General Hospital and Harvard Medical School, Boston, MA; Solmaz Sahebjam, Moffitt Cancer Center, University of South Florida, Tampa, FL; Serena Desideri, Xiaobu Ye, and Stuart Grossman, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore; S. Percy Ivy, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD; L. Burt Nabors, University of Alabama at Birmingham, Birmingham, AL; and Michael Prados, University of California at San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.1525DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857195PMC
October 2015

EGFR blockade prevents glioma escape from BRAFV600E targeted therapy.

Oncotarget 2015 Sep;6(26):21993-2005

Departments of Pediatrics, University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.4014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673141PMC
September 2015

The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma.

Neurosurgery 2015 Aug;77(2):248-53; discussion 253

Departments of *Neurological Surgery, ‡Epidemiology and Biostatistics, and §Neurology, University of California at San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0000000000000766DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506198PMC
August 2015

Toward precision medicine in glioblastoma: the promise and the challenges.

Neuro Oncol 2015 Aug 1;17(8):1051-63. Epub 2015 May 1.

University of California San Francisco, San Francisco, California (M.D.P, J.J.P., A.M.M., S.M.C.); Translational Genomics Research Institute, Phoenix, Arizona (S.A.B., N.L.T., W.D.T., J.A.K., M.E.B., D.W.C., J.D.C., J.M.T.); Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (K.L.L., P.Y.W.); University of Texas Health Science Center, San Antonio, Texas (J.G.K.); Memorial Sloan-Kettering Cancer Center, New York, New York (I.K.M.); The University of Texas M.D. Anderson Cancer Center, Houston, Texas (J.F.d.G.); University of Utah Huntsman Cancer Institute, Salt Lake City, Utah (H.C.); University of California Los Angeles, Los Angeles, California (T.F.C.); Iowa Spine and Brain Institute, Waterloo, Iowa (T.C.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490873PMC
August 2015

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.

J Clin Oncol 2015 Aug 13;33(24):2646-54. Epub 2015 Jul 13.

Giles W. Robinson, Brent A. Orr, Gang Wu, Tong Lin, Ibrahim Qaddoumi, Sue C. Kaste, Michael Rusch, Sariah J. Allen, Arzu Onar-Thomas, Clinton F. Stewart, James M. Boyett, Richard J. Gilbertson, David W. Ellison, and Amar Gajjar, St Jude Children's Research Hospital, Memphis, TN; Sridharan Gururangan and Annick Desjardins, Duke University Medical Center, Durham, NC; Roger J. Packer, Children's National Medical Center, Washington, DC; Stewart Goldman, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL; Michael D. Prados, University of California San Francisco, San Francisco, CA; Murali Chintagumpala, Texas Children's Cancer Center, Houston, TX; Naoko Takebe, National Cancer Institute, Bethesda, MD; Maryam Fouladi, Cincinnati Children's Hospital, Cincinnati, OH; and Tom Curran, Children's Hospital of Philadelphia, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.1591DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534527PMC
August 2015

Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence.

Neurosurgery 2015 Aug;62 Suppl 1:160-5

*Department of Neurological Surgery, ‡Department of Epidemiology and Biostatistics, and §Department of Neurology, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0000000000000801DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260825PMC
August 2015

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.

N Engl J Med 2015 Jun 10;372(26):2499-508. Epub 2015 Jun 10.

From the Departments of Health Sciences Research (J.E.E.-P., P.A.D., H.S., M.L.K.), Laboratory Medicine and Pathology (D.H.L., G.S., A.A.C., T.M.K., C.E.P., A.R.C., C.H., C.G., R.B.J.), Neurology (D.H.L., B.P.O.), and Oncology (J.C.B.), Mayo Clinic, Rochester, MN; the Departments of Neurological Surgery (A.M.M., K.M.W., T.R., I.V.S., H.M.H., L.S.M., S.Z., A.P., M.S.B., S.M.C., M.D.P., J.K.W., M.R.W.), Epidemiology and Biostatistics (A.M.M., P.M.B., J.W., J.K.W., M.R.W.) and Pathology (M.P., R.M., G.F.R., A.P., T.T.) and the Institute of Human Genetics (J.W., J.K.W., M.R.W.), University of California, San Francisco, and the Bioinformatics Core, Gladstone Institutes (A.R.P.) - all in San Francisco; and the Department of Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York (J.T.H.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1407279
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1407279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489704PMC
June 2015

Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients.

Neuro Oncol 2015 Mar 13;17(3):440-7. Epub 2014 Aug 13.

Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (E.V.-B., M.R.G.); Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (K.A., K.W.); Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (Y.Y., J.W.); Office of Multicenter Clinical Research, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (M.J.N.-R.); Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (H.C.); Division of Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, California (G.D.); Departments of Neurology and Medicine (Medical Oncology), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (F.S.L.); Department of Neurosurgery, Assistance Publique-Hopitaux de Marseille, Aix-Marseille University, Marseille, France (P.M.); Departments of Neurology & Neurosurgery, Henry Ford Hospital, Detroit, Michigan (T.M.); Department of Neurology, Memorial-Sloan Kettering Cancer Center, New York, New York (A.O.); Department of Neurology, Stanford University & Lucile Packard Children's Hospital, Palo Alto, California (S.P.); Department of Neuro-Oncology, UCSF Helen Diller Comprehensive Cancer Center, San Francisco, California (M.P.); Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin (H.I.R.); Department of Neuroscience, University San Giovanni Battista Hospital, Turin, Italy (R.S.); Department of Neurosurgery, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina (J.W.); Department of Family Health, School of Nursing, The University of Texas Health Science Center-Houston, Houston, Texas (T.S.A.); CERN Foundation, Dayton, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483095PMC
March 2015

Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group.

Neuro Oncol 2015 Feb 26;17(2):180-8. Epub 2014 Aug 26.

Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (B.M.A., L.T., K.L.L., P.Y.W.); Mayo Clinic, Rochester, Minnesota (E.G., K.V.B., B.P.O., J.N.S.); The University of Texas M.D. Anderson Cancer Center, Houston, Texas (W.K.A.Y., J.F.D., D.A.B.); St. Jude Children's Research Hospital, Memphis, Tennessee (J.M.B.); University of California, Los Angeles, California (T.F.C.); Memorial Sloan-Kettering Cancer Center, New York, New York (J.T.H., I.K.M.); National Cancer Institute, Bethesda, Maryland (B.M., A.T.-A.); Princess Margaret Cancer Centre, Toronto, Ontario, Canada (W.M.); Henry Ford Hospital, Detroit, Michigan (T.M.); University of California, San Diego, La Jolla, California (P.S.M.); University of California, San Francisco, California (M.D.P.); Johns Hopkins University, Baltimore, Maryland (X.Y.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288520PMC
February 2015

Familial gliomas: cases in two pairs of brothers.

J Neurooncol 2015 Jan 11;121(1):135-40. Epub 2014 Sep 11.

Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Ave., Rm M779, San Francisco, CA, 94143-0112, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-014-1611-2DOI Listing
January 2015

Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab.

J Neurooncol 2015 Jan 29;121(2):331-9. Epub 2014 Oct 29.

Department of Radiology and Biomedical Imaging, University of California, San Francisco (UCSF), 1700 4th Street, Byers Hall, Box 0775, San Francisco, CA, 94143-0775, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-014-1636-6
Publisher Site
http://dx.doi.org/10.1007/s11060-014-1636-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311062PMC
January 2015

Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD).

Neuro Oncol 2014 Oct;16 Suppl 7:vii36-47

Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (P.Y.W., D.A.R.); University of California, Los Angeles School of Medicine, Los Angeles, California (T.F.C., B.M.E., W.B.P.); New York University Langone Medical Center, New York, New York (H.A.F.); Hoffmann-La Roche, Basel, Switzerland (L.A.); Department of Biostatistics, Mayo Clinic Rochester, Rochester, Minnesota (K.B.); Department of Neuro-radiology, University of Heidelberg, Heidelberg, Germany (M.B.); Department of Medical Oncology, Mayo Clinic Rochester, Rochester, Minnesota (J.B.); Brain Tumor Center, University of California, San Francisco, California (S.M.C., M.D.P.); Siemens Healthcare North America, Malvern, Pennsylvania (A.G.S.); Department of Neuro-Oncology, Erasmus M.C.-Daniel den Hoed Cancer Center, Rotterdam, Netherlands (M.v.d.B.); Department of Neuro-Oncology, M.D. Anderson Cancer Center, Houston, Texas (W-K.A.Y.).

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nou226DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195530PMC
October 2014

Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma.

Neuro Oncol 2014 Sep 26;16(9):1255-62. Epub 2014 Mar 26.

Department of Neurological Surgery, University of California, San Francisco, California (S.J.H., J.D.R., A.M.M., J.L.C., M.D.P., S.M.C., M.S.B., A.D., N.A.B.); Department of Epidemiology and Biostatistics, University of California, San Francisco, California (A.M.M.).

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nou044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136897PMC
September 2014

Plexiform neurofibromas, trial design, and the definitions of "progression" and "treatment failure".

Authors:
Michael D Prados

Neuro Oncol 2014 May 8;16(5):617-8. Epub 2014 Apr 8.

University of California San Francisco, Department of Neurological Surgery, Neuro-Oncology Service, 400 Parnassus, Room A-808, San Francisco, California 94143-0372.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984566PMC
May 2014

Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.

Neuro Oncol 2014 Apr 26;16(4):567-78. Epub 2014 Jan 26.

Center for Neuro-Oncology, Dana Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (P.Y.W., A.D.N., J.D.); Department of Neurosurgery, University of California, San Francisco, San Francisco, California (S.M.C., K.R.L., M.D.P.); University of Texas Health Science Center, San Antonio, Texas (J.G.K.); Division of Neuro-Oncology, Department of Neurology, University of California, Los Angeles, Los Angeles, California (T.F.C.); University of Wisconsin, Madison Wisconsin (H.I.R., M.P.M.); Neurooncology Program, Division of Hematology/Oncology, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, Pennsylvania (F.S.L.); Division of Neuro-Oncology, MD Anderson Cancer Center, Houston, Texas (M.R.G., M.D.G., W.K.A.Y., K.D.A.); Center for Molecular Oncologic Pathology, Dana Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (S.S., A.H.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.S., A.H.L., K.L.L.); Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland (J.D.*, J.J.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not247DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956354PMC
April 2014

"We will know it when we see it;" bevacizumab and glioblastoma.

Authors:
Michael D Prados

Neuro Oncol 2014 Apr;16(4):469-70

University of California San Francisco, Department of Neurological Surgery, Neuro-Oncology Service, 400 Parnassus, Room A-808, San Francisco, CA 94143-0372.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956364PMC
April 2014

Targeting Wee1 for the treatment of pediatric high-grade gliomas.

Neuro Oncol 2014 Mar 4;16(3):352-60. Epub 2013 Dec 4.

Department of Neurology, University of California, San Francisco, San Francisco, California (S.M., I.K.); Department of Pediatrics, University of California, San Francisco, San Francisco, California (S.M., M.D.P., N.G.); Brain Tumor Research Center, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California (S.M., R.H., X.Y., A.K.O., J.P., M.W.T., C.D.J., M.S.B., N.G., D.A.H.-K.); Department of Neurological Surgery, University of California, San Francisco, San Francisco, California (S.M., J.P., I.S., M.D.P., C.D.J., M.S.B., N.G., D.A.H.-K.); Department of Radiation Oncology, University of California, San Francisco, San Francisco, California (D.A.H.-K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not220DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922515PMC
March 2014

Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial.

Neuro Oncol 2014 Jan 12;16(2):274-9. Epub 2013 Dec 12.

Corresponding Author: Andrew T. Parsa, MD, PhD, Professor and Chair, Department of Neurological Surgery, Northwestern University, Feinberg School of Medicine, 676 N. St. Clair Street, Suite 2210, Chicago, IL 60611.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895386PMC
January 2014

The somatic genomic landscape of glioblastoma.

Cell 2013 Oct;155(2):462-77

Human Oncology and Pathogenesis Program, Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, Department of Neurological Surgery, Weill Cornell Medical Center, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
https://www.genome.gov/Multimedia/Slides/TCGA2/27_Verhaak.pd
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S009286741301208
Publisher Site
http://dx.doi.org/10.1016/j.cell.2013.09.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910500PMC
October 2013

Feasibility, safety, and indications for surgical biopsy of intrinsic brainstem tumors in children.

Childs Nerv Syst 2013 Aug 11;29(8):1313-9. Epub 2013 May 11.

Department of Neurological Surgery, Pediatric Neurosurgery, University of California, San Francisco, 505 Parnassus Ave, Room M779, San Francisco, CA 94143-0112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00381-013-2101-0DOI Listing
August 2013

Gliosarcoma arising from an oligodendroglioma (oligosarcoma).

Clin Neuropathol 2013 May-Jun;32(3):165-70

Department of Pathology, University of California San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5414/NP300577DOI Listing
June 2013

Subependymal spread of recurrent glioblastoma detected with the intraoperative use of 5-aminolevulinic acid: case report.

J Neurosurg 2013 Jun 19;118(6):1220-3. Epub 2013 Feb 19.

Department of Neurological Surgery, University of California, San Francisco, California 94143-0112, USA.

View Article

Download full-text PDF

Source
https://thejns.org/view/journals/j-neurosurg/118/6/article-p
Publisher Site
http://dx.doi.org/10.3171/2013.1.JNS121537DOI Listing
June 2013

An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing.

J Neurooncol 2012 May 10;108(1):29-35. Epub 2012 Jan 10.

Department of Neurological Surgery and Brain Tumor Research Center, University of California San Francisco, San Francisco, CA 94143-0112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-011-0796-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841009PMC
May 2012

Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment.

Neurosurgery 2012 Feb;70(2):361-70

Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94143-0112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0b013e3182314f9dDOI Listing
February 2012

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.

J Neurooncol 2012 Jan 8;106(1):147-53. Epub 2011 Jul 8.

Department of Neuro-oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-011-0650-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351869PMC
January 2012

Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy.

J Neurooncol 2012 Jan 9;106(2):367-75. Epub 2011 Aug 9.

Department of Radiation Oncology, University of California, San Francisco and UCSF Benioff Children's Hospital, 1600 Divisadero Street, Suite H1031, San Francisco, CA 94115-1708, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%252Fs11060-011-
Web Search
http://link.springer.com/10.1007/s11060-011-0671-9
Publisher Site
http://dx.doi.org/10.1007/s11060-011-0671-9DOI Listing
January 2012

Investigation of intravenous delivery of nanoliposomal topotecan for activity against orthotopic glioblastoma xenografts.

Neuro Oncol 2011 Dec 27;13(12):1288-95. Epub 2011 Sep 27.

Department of Neurological Surgery, University of California-San Francisco, 1450 Third St, San Francisco, CA 94158, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nor139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223095PMC
December 2011

Conditional probability of survival in patients with newly diagnosed glioblastoma.

J Clin Oncol 2011 Nov 3;29(31):4175-80. Epub 2011 Oct 3.

Biometric Research Branch, National Cancer Institute, National Institute of Health, Room 8124, Executive Plaza North, 6130 Executive Blvd, Rockville, MD 20892, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2010.32.4343
Publisher Site
http://dx.doi.org/10.1200/JCO.2010.32.4343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208537PMC
November 2011

Identifying the needs of brain tumor patients and their caregivers.

J Neurooncol 2011 Sep 11;104(3):737-44. Epub 2011 Feb 11.

Division of Neuro-Oncology in the Department of Neurosurgery, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-011-0534-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170122PMC
September 2011

Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab.

Neuro Oncol 2011 Jun 9;13(6):660-8. Epub 2011 May 9.

Section of Neuropsychology, Department of Neuro-Oncology, Unit 431, The University of Texas MD Anderson Cancer Center, P.O. Box 301402, Houston, TX 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nor024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107095PMC
June 2011

A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03.

Neuro Oncol 2011 May 3;13(5):509-16. Epub 2011 Mar 3.

Neuro-Oncology Branch, National Cancer Institute, National Institute of Neurological Disorder and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nor017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093337PMC
May 2011